Strategic Planning– R&D landscape, prioritization and strategies

‘The client has diversified their pharmaceutical business and focused on women’s health, urology and internal medicine as their therapeutic focus in their R&D in recent years; however, their R&D strategies were immature and less strategic to develop a novel compounds compared with their competitors. The client engaged GlobalData to support on their R&D strategy and roadmap development in 2020.

Our Solution

The GlobalData team undertook a comprehensive and extensive secondary research including Pharma IC, professional journal reviews and web sites across the US, Europe and Japanese market. The aim of the research was to capture the current treatment landscape, pipeline activity, unmet medical needs in women’s health indications and urological disorder indications across 5 MM and compare the difference.

Outcome

The comprehensive and user friendly interactive prioritization model were delivered to the client. The accompanying report covered an overview of disease, treatment landscape, unmet medical needs, and pipeline activity across 5 MM.

DECODED Your daily industry news round-up

This site is registered on wpml.org as a development site.